Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Elutia Inc., 3 years.
Elutia Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 22, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −1,687 | $1.86 | $3,138 |
| Jan 21, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −2,473 | $1.81 | $4,476 |
| Jan 16, 2026 | Acumen Pharmaceuticals Inc. | Grant or award | +99,133 | — | — |
| Jan 8, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −6,888 | $1.82 | $12,536 |
| Jan 7, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −4,105 | $2.00 | $8,210 |
| Jan 7, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −1,700 | $1.99 | $3,383 |
| Jan 6, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −5,100 | $1.97 | $10,047 |
| Jan 5, 2026 | Acumen Pharmaceuticals Inc. | Open-market sale | −4,000 | $1.96 | $7,840 |
| Jan 23, 2025 | Acumen Pharmaceuticals Inc. | Open-market sale | −28,902 | $1.72 | $49,711 |
| Jan 21, 2025 | Acumen Pharmaceuticals Inc. | Open-market sale | −4,364 | $1.60 | $6,982 |
| Jan 6, 2025 | Acumen Pharmaceuticals Inc. | Grant or award | +66,800 | — | — |
| Jan 3, 2025 | Acumen Pharmaceuticals Inc. | Open-market sale | −13,235 | $1.84 | $24,352 |
| Jan 18, 2024 | Acumen Pharmaceuticals Inc. | Open-market sale | −4,242 | $3.71 | $15,738 |
| Jan 2, 2024 | Acumen Pharmaceuticals Inc. | Grant or award | +106,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.